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Increased renal ANP synthesis, but decreased or unchanged
cardiac ANP synthesis in water-deprived and salt-restricted rats.
Background. Experiments were performed to examine the effect
of water deprivation and salt restriction on ANP synthesis in the
kidneys and hearts of normal rats.
Methods. A 4-day water deprivation (WD) and 7-day salt restric-
tion (SR; 0.01% NaCl) were performed in 12 and 14 rats, respec-
tively. Atrial natriuretic peptide (ANP) mRNA expression in the
kidney was assessed with reverse transcription-polymerase chain
reaction coupled with Southern blot hybridization, while the ANP
mRNA in the hearts was measured by Northern blot hybridization.
ANP and angiotensin II concentrations in the extracted plasma were
measured by radioimmunoassay. The molecular form of renal ANP-
like protein was characterized by reverse phase—high-performance
liquid chromatography (RP-HPLC).
Results. Renal outer and inner medullary ANP mRNA showed a
respective 11-fold and ninefold increase in WD rats, and an eightfold
and fivefold increase in SR rats as compared to corresponding
control groups. Inversely, cardiac atrial ANP mRNA and plasma
ANP were decreased in WD rats, whereas they did not change in the
SR group. Plasma angiotensin II concentration increased in conjunc-
tion with the decrease of urine sodium excretion in both groups.
RP-HPLC analysis revealed a 45% extraction of ANP in the WD rat
kidneys, whereas only 3% ANP in the control kidneys migrated in a
molecular form similar to cardiac atrial proANP.
Conclusions. Our results demonstrate that water deprivation
and salt restriction markedly enhance renal ANP mRNA, whereas
water deprivation suppresses cardiac atrial ANP mRNA and
plasma ANP concentrations. The current study indicates that
renal ANP and cardiac atrial ANP appear to be two distinct
systems regulated by different mechanisms and possibly exhibiting
different intra-renal paracrine and systemic endocrine functions.
Atrial natriuretic peptide (ANP), secreted primarily by
the cardiac atrium [1], has been known to possess potent
diuretic, natriuretic, vasorelaxant, and aldosterone-inhibi-
tory activities [2–4]. Increased intravascular blood volume
has been found to enhance atrial ANP synthesis and plasma
ANP concentration [5–7], whereas volume depletion causes
opposite alterations [8, 9]. Using the immunocytochemical
technique and cDNA probes, the presence of proANP-like
immunoreactive peptide and ANP mRNA was found in
extra-atrial organs [10–13], including the kidney [14–16].
Using reverse transcription-polymerase chain reaction
(RT-PCR) followed by Southern blot analysis, we recently
demonstrated that renal ANP synthesis was markedly en-
hanced in deoxycorticosterone acetate (DOCA) salt-
treated [17] and diabetic [18] rats. This finding, namely that
plasma renin activity was suppressed in DOCA salt-treated
[17] and diabetic [18] rats, indicates that the increase of
renal ANP synthesis may be responsive to volume expan-
sion. In the above experiments [17, 18], daily urinary ANP
excretion showed a significant correlation with daily urinary
sodium excretion and daily urine volume. Thus, we sug-
gested that ANP synthesized from the kidney may produce
natriuretic and diuretic action in volume-expanded status.
However, the exact pathophysiological significance and the
regulation of ANP synthesized from the kidney remain to
be clarified. To investigate the action of renal-derived ANP
and its regulation, it is necessary to first elucidate the
change of ANP gene message in the kidney and urinary
ANP excretion in volume-depleted status. We hypothesized
that both renal and cardiac ANP synthesis might decrease
in volume-depleted disorders. Therefore, in the present
study, ANP mRNA levels were measured in the kidney and
the heart, and plasma and urine ANP levels of normal rats
were measured after four days of water deprivation and
seven days of salt restriction. Rather surprisingly, increased
renal ANP mRNA and urine ANP excretion rates with
decreased or unchanged cardiac ANP synthesis were found
in water-deprived and salt-restricted rats.
METHODS
Animal experiments
Experiments were performed on male Wistar rats weigh-
ing 262 to 308 g. These rats were individually housed in
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metabolic cages for seven days before the start of the three
experiments. In experiment 1, the influence of water depri-
vation on renal ANP synthesis was investigated. Twelve
normal rats were completely water depleted (WD) from the
first to the fourth days. Fourteen body weight- and age-
matched rats were included as normal controls (NC1), and
were provided normal rat chow diet (0.20% NaCl) and tap
water ad libitum. In experiment 2, the influence of salt
restriction on renal ANP synthesis was studied. Fourteen
normal rats were maintained on NaCl-restricted diet (ad-
dition of 0.01% NaCl to catalog no. 960232; ICN Biochemi-
cals, Irvine, CA, USA) and distilled water ad libitum (SR)
from the first to the seventh days. Another group of 15 body
wt- and age-matched normal rats were studied as controls
(NC2) and given 0.26% NaCl food (catalog no. 905453;
ICN Biochemicals) and tap water ad libitum during the
study period. All rats were sacrificed by decapitation to
collect blood for the measurement of plasma ANP, angio-
tensin II, arginine vasopressin (AVP) and sodium level on
the end day of both experiments. Kidneys, cardiac atria and
ventricles were removed, and renal tissues were immedi-
ately divided into cortex, outer and inner medulla for ANP
mRNA analysis. Urine sodium and ANP immunoreactivity
were also measured on days 4 and 7 in experiments 1 and
2, respectively. In experiment 3, the identity of this renal
ANP-like protein was further characterized by its migratory
properties by using reverse phase—high-performance liq-
uid chromatography (RP-HPLC). Six normal control and
water-deprived rats were killed by decapitation, and trunk
blood was collected into ice-cooled tubes containing 500
KIU/ml aprotinin (Sigma, St. Louis, MO, USA) and 1
mg/ml ethylenediaminetetraacetic acid, and immediately
centrifuged. The kidneys and cardiac atria were rapidly
removed and immediately extracted.
RNA isolation and reverse transcription
Total RNA was extracted from the renal cortex, outer
and inner medulla, cardiac atrium and ventricle using a
modified guanidium isothiocyanate method [19]. Two mi-
crograms of total RNA from renal cortex, outer and inner
medulla were reverse transcribed by incubating with a 20 ml
reverse transcription mixture containing: 20 pmole oligo
(dT)18 primer, 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM
MgCl2, 20 units of RNase inhibitor, 0.5 mM dNTPs, and 50
U of MMLV reverse transcriptase (Stratagene Laborato-
ries Inc., Palo Alto, CA, USA) at 37°C for two hours. The
reverse transcriptase was inactivated by heating for five
minutes at 94°C.
Polymerase chain reaction amplification and Southern
blot hybridization
Primers for the PCR were designed to flank at least
one putative intron site for rat ANP and b-actin. For ANP,
the sense primer (59-ATGGGCTCCTTCTCCATCACC-39)
corresponded to base pair 1 to 21, and antisense primer
(59-TGTTATCTTCGGTACCG-39) corresponded to bp
445 to 461 of rat ANP cDNA. For b-actin, the sense primer
(59-CGT AAAGACCTCTATGCCAA-39) corresponded to
bp 2750 to 2769, and the antisense primer (59-AGCCAT
GCCAAATGTCTCAT-39) corresponded to bp 3203 to
3222 of rat b-actin gene. The size of expected PCR
products was 461 bps for ANP and 349 bps for b-actin. For
amplification, PCR was performed at a final concentration
of 1 3 PCR buffer (10 mM Tris-HCl, pH 8.3; 50 mM KCl;
1.5 mM MgCl2), 0.2 mM dNTP, 0.4 mM sense and antisense
oligos, 2.0 units of Taq DNA polymerase (Boehringer
Mannheim, Indianapolis, IN, USA) to a total volume of 50
ml. The amplification cycles were 45 seconds at 94°C, 45
seconds at 60°C and 90 seconds at 72°C in a Perkin-Elmer
Cetus 9600 thermocycler (Perkin-Elmer Cetus, Norwalk,
CT, USA). The cycle for the amplification of ANP mRNA
was repeated 30 times for renal cortex, outer medulla, and
inner medulla as described in our previous studies [17, 18].
The amplified products were then electrophoresed on 1.5%
agarose gels and transferred to nylon membranes (Schlei-
cher & Schuell GmbH, Dassel, Germany). The blots were
hybridized with [32P] labeled, randomly-primed, 426 bp rat
ANP cDNA prepared by PCR cloning of the rat atria
extracts for 16 hours at 65°C, according to the standard
technique [20]. After each hybridization, the blots were
washed twice in a solution containing 0.1% sodium dodecyl
sulfate (SDS) and 23SSC (0.3 M NaCl, 30 mM sodium
citrate) for 15 minutes at room temperature and then twice
in 0.1% SDS and 0.13SSC at 65°C. Blots were exposed to
Kodak BIOMAX-MR (Eastman Kodak Company, Roch-
ester, NY, USA) film at 270°C. A radioisotope-labeled
probe for b-actin used as an internal control was also made
using the primer extension method. After autoradiography,
the x-ray film was scanned by a laser densitometer (Molec-
ular Dynamics, Sunnyvale, CA, USA), and the data were
analyzed by MD ImageQuant software release version 3.22.
The value obtained for each ANP PCR product was
normalized by its b-actin levels. To control the accuracy of
RT-PCR followed by Southern hybridization, serially di-
luted total RNA of renal tissues were subjected to RT-PCR
amplification. Moreover, the intra-assay variation of semi-
quantitative RT-PCR followed by Southern blot analysis
from renal tissues was analyzed.
Northern blot hybridization
RNA samples (20 mg/lane) were denatured, electropho-
resed through 1% agarose gel containing 1.1% formalde-
hyde, and transferred onto the nylon membrane. Hybrid-
ization was carried out at 42°C with a randomly primed,
[32P]-labeled rat ANP cDNA probe. The membranes were
washed twice in 2 3 SSC and 0.1% SDS at room temper-
ature, and were then further washed in 0.2 3 SSC and 0.1%
SDS at 65°C. The membranes were then exposed to Kodak
BIOMAX-MR film (Eastman-Kodak) at 270°C with the
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aid of an intensifying screen. Membranes were subse-
quently rehybridized with a 700-bp pstI fragment of a
b-actin probe to correct for differences in RNA loading.
The signals on the autoradiograph were scanned and
analyzed.
Extraction of plasma, renal and cardiac tissues
Kidneys and atria were minced and boiled for five
minutes in 10 vol 0.1 M acetic acid. Once cooled to 4°C, the
acid tissues were homogenized with a Polytron homoge-
nizer (Janke & Kunkel IKA-Labortechnik, Germany) for
60 seconds. The homogenate was centrifuged at 4500 rpm
for 40 minutes at 4°C. The acid supernatants were then
extracted using Sep-Pak C18 cartridges (Waters Associates,
Milford, MA, USA) that were premoisturized with 4 ml of
60% acetonitrile (ACN) in 0.1% trifluoacetic acid (TFA).
The cartridges with the absorbed peptides were washed
with 6 ml of 0.1% TFA and then eluted with 3 ml of 60%
ACN in 0.1% TFA. Plasma samples were also extracted
using Sep-Pak C18 cartridges as described for renal and
atrial tissues. The eluates were lyophilized and reconsti-
tuted for RP-HPLC and RIA.
Characterization of plasma, renal and atrial ANP
profiles by RP-HPLC
The dry eluates were reconstituted in HPLC buffer A
(10% ACN in 0.1% TFA). The HPLC analysis was per-
formed with a Beckman System Gold HPLC system,
equipped with a reverse-phase column (Cosmosil 5C18-AR
Column; Nacacai Tesque Inc., Kyoto, Japan). The column
was equilibrated at room temperature with buffer A and
eluted by increasing the ACN concentration (buffer B, 60%
ACN-0.1% TFA). The starting buffer was 100% buffer B.
A linear gradient elution system was employed using from
10 to 60% ACN by an increase in the ACN of 0.5% per
minute. The flow rate was 1 ml/min, and fraction collection
was 0.5 ml/tube. The collections were lyophilized and
reconstituted for RIA.
Assay methods
ANP, AVP and angiotensin II immunoreactivities from
samples of plasma and ANP from urine were determined
by radioimmunoassay methods after extraction as previ-
ously reported [17, 18]. Briefly, 3 ml of plasma were passed
through Sep-Pak C18 cartridges (Waters Corporation) and
eluted with 5 ml 60% ACN in 0.1% TFA. The eluate was
lyophilized and reconstituted for RIA. The concentrations
of plasma and urinary sodium and plasma osmolality levels
were determined in an automatic analyzer (Nova Biochem-
ical, Newton, MA, USA).
Statistical analysis
The data are expressed as mean values 6 SEM. To test the
difference between the two groups, an unpaired Student’s
t-test was performed. A P value ,0.05 was considered
statistically significant.
RESULTS
The characteristics of NC1 and WD groups on the fourth
study day are shown in Table 1. The mean amount of daily
water intake in NC1 group was 26.5 6 1.5 ml, whereas the
complete water deprivation was performed in the WD
group. Body wt and kidney wt in WD rats were significantly
decreased as compared to NC1 rats. The mean plasma
AVP and angiotensin II levels were significantly increased
along with the elevation of mean plasma sodium and
osmolality levels, whereas plasma ANP concentrations
were significantly decreased in the WD group after a
four-day water deprivation. The mean daily urinary sodium
excretion and urine volume were significantly decreased in
WD rats in comparison to NC1 group. However, the
urinary ANP excretion rates were increased on the fourth
day in WD rats.
RT-PCR coupled with Southern blot analysis revealed a
461 bp product for ANP from rat kidney tissue RNA
extracts. To determine the relative changes in tissue ANP
mRNA expression, the yield of ANP PCR products was
normalized to the amount of b-actin cDNA amplified from
the same RT cDNA of tissue samples, a method that has
been used in our previous reports [17, 18]. The accuracy of
the semiquantitative RT-PCR with Southern hybridization
in this study was also tested. Serial dilutions (0.4, 0.8, 1.2,
1.6, 2.0 and 2.4 mg) of total RNA were subjected to
RT-PCR amplification f or ANP and b-actin, respectively.
The correlation coefficients between RNA concentrations
and corresponding densities from renal cortex, outer and
inner medulla were: (1) for ANP mRNA, r 5 0.968, r 5
0.992 and r 5 0.966; (2) for b-actin mRNA, r 5 0.972, r 5
0.958 and r 5 0.963. An intra-assay test of RT-PCR
followed by Southern blot analysis in 2.0 mg total RNA
extracted from renal tissues was performed. The variation
Table 1. Characteristics of normal control (NC1) and water-deprived
normal (WD) rats on the fourth study day
NC1 WD
Number 14 12
Body weight, g 311 6 5.0 261 6 9.18a
Kidney weight, g 1.59 6 0.03 1.25 6 0.03a
KW/BW, g/g (31023) 3.69 6 0.05 3.47 6 0.09c
Water intake, ml/24 hr 26.5 6 1.5 0a
UV, ml/24 hr 16.5 6 0.9 2.3 6 0.1a
Blood glucose, mg/dl 125 6 4.3 107 6 6.5b
Plasma sodium, mmol/liter 140 6 1.8 149 6 1.6b
Plasma osmolality, mOsm/kg 287 6 2.2 299 6 2.2b
Plasma ANP, pg/ml 42 6 3.7 24 6 2.2a
Plasma AVP, pg/ml 1.4 6 0.03 2.1 6 0.16a
Plasma angiotensin II, pg/ml 18 6 1.1 197 6 32.6a
UNaV, mmol/24 hr 0.62 6 0.04 0.15 6 0.02
a
UANPV, pg/24 hr 44 6 6.6 673 6 84
a
Values are mean 6 SEM.
a p , 0.001, b p , 0.01, c p , 0.05 vs. NC1
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coefficients were 5.6%, 6.8% and 7.2% for ANP mRNA
(N 5 8), and 7.3%, 5.2% and 6.6% for b-actin mRNA (N 5
8) in renal cortex, outer and inner medullas, respectively.
Figure 1 shows the autoradiographs of RT-PCR ampli-
fication of ANP and b-actin mRNA in the renal cortex,
outer and inner medullas from six representative NC1 and
five representative WD rats on day 4. The relative ratios of
the densitometry measures of the PCR products for ANP
and b-actin mRNA from 14 NC1 and 12 WD rats are
shown in Figure 1B. The relative ratio of PCR products for
ANP and b-actin mRNA from renal outer and inner
medulla in the WD group increased 11 and 9 times as
compared with those in NC1 group; no significant differ-
ence for ANP mRNA expression in the renal cortex was
found between NC1 and WD rats.
Table 2 shows the characteristics of NC2 and SR groups
on the seventh day. The mean body wt value was signifi-
cantly decreased while mean kidney wt value was not
changed in the SR group as compared to the NC2 group.
The mean daily water intake and urine amount, as well as
plasma sodium and osmolality levels in SR rats were not
Fig. 1. (A) Autoradiographs of the
amplification of ANP and b-actin mRNA by
RT-PCR followed by Southern blot analysis in
renal cortex, outer and inner medullas from 6
representative normal control (NC1) and 5
representative water-deprived normal (WD)
rats on the fourth day after complete water
deprivation in the WD group. Each lane
represents an individual rat. (B) Relative ratios
(mean 6 SEM) of the densitometry readings for
RT-PCR amplification of ANP and b-actin
mRNA in the cortex, outer and inner medulla
from 14 normal control (NC1) and 12 water-
deprived (WD) rats after a 4-day water
deprivation. *P , 0.001 versus the NC1 group.
Table 2. Characteristics of normal control (NC2) and salt-restricted
normal (SR) rats on the seventh study day
NC2 SR
Number 15 14
Body weight, g 314 6 3.0 280 6 3.4a
Kidney weight, g 1.48 6 0.02 1.46 6 0.04
Water intake, ml/24 hr 28.1 6 1.6 23.5 6 1.9
UV, ml/24 hr 18.2 6 1.4 13.6 6 2.2
Plasma sodium, mmol/liter 142 6 1.0 144 6 1.5
Plasma osmolality, mOsm/kg 288 6 2.3 288 6 4.1
Plasma ANP, pg/ml 37.2 6 4.2 28.5 6 3.7
Plasma AVP, pg/ml 1.5 6 0.08 1.8 6 0.17
Plasma angiotensin II, pg/ml 22 6 2.3 64 6 5.0a
UNaV, mmol/24 hr 0.65 6 0.05 0.04 6 0.01
a
UANPV, pg/24 hr 68 6 7.1 235 6 70.2
b
Values are mean 6 SEM.
a P , 0.01, b P , 0.05 vs. NC2
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different from those of NC2 group. The mean plasma
angiotensin II value was significantly increased, while there
was no significant difference in the plasma AVP and ANP
concentrations between the SR rats and NC2 group. The
mean daily urinary sodium excretion rate was significantly
decreased, but the mean urinary ANP excretion rate was
increased on the seventh salt-restricted day in the SR group
when compared to the NC2 group.
Autoradiographs of the RT-PCR amplification of ANP
and b-actin mRNA in the renal cortex, outer and inner
medullas from three representative NC2 and SR rats on the
seventh study day are shown in Figure 2. The relative ratios
of the densitometry measures of the PCR products for
ANP and b-actin mRNA from the two groups are shown in
Figure 2B. The relative ratios of PCR products for ANP
and b-actin mRNA from renal outer and inner medullas of
14 SR rats increased 8 and 5 times when compared with the
ratios of 15 rats in the NC2 group. No significant difference
for ANP mRNA expression in the renal cortex was found
between the NC2 and SR groups.
The RP-HPLC analysis of the ANP molecular form is
shown in Figure 3. In normal rat kidneys (Fig. 3A), the
majority (92%) of irANP comigrated with synthetic rat
a-ANP-(1-28), while a small amount (3%) of total irANP
migrated with an molecular form of proANP as compared
with the HPLC profile of atrial extract from the NC and
WD rats. The ANP molecular profile from kidneys ex-
tracted from these rats with a four-day water deprivation
were markedly different when compared with normal kid-
neys. Approximately 45% of the extracted irANP in the
WD rat kidneys (Fig. 3B) migrated at an apparent molec-
ular form similar to heart proANP, whereas 46% of irANP
comigrated with synthetic rat a-ANP-(1-28). To determine
whether the existence of ANP prohormone in the WD rat
kidney was the result of ANP extraction from the plasma,
we analyzed the molecular form of plasma ANP in control
(Fig. 3C) and water-deprived (Fig. 3D) rat plasma by
RP-HPLC. The results revealed only ANP-(1-28), but not
pro-ANP, in the plasma of both groups.
Figure 4A is an autoradiograph of a Northern blot of
right atrial and left ventricular ANP and b-actin RNA
extracted from two representative NC1 and two WD rats
that were sacrificed on the fourth study day. Figure 4B
shows the relative ANP mRNA and b-actin mRNA levels
from 14 NC1 and 12 WD rats. The relative ratio of ANP
and b-actin mRNA levels of right atrium from WD rats was
significantly decreased as compared to NC1 rats, while no
difference in the left ventricular ANP mRNA level was
observed between the NC1 and WD groups. Figure 5 is
Northern blot analysis of mRNA for ANP and b-actin in
the tissues of right atria and ventricles from two represen-
tative NC2 and two SR rats; Fig. 5B demonstrates that
there was no significant difference to be found for the
relative ratio of ANP and b-actin mRNA from cardiac
atrium or ventricles between 15 NC2 and 14 SR rats.
DISCUSSION
In the present study, we have demonstrated the influence
of water deprivation and salt restriction on renal and
cardiac ANP synthesis in normal rats. These results are: (1)
renal medullary ANP mRNA expression was markedly
enhanced after a four-day water deprivation and seven-day
Fig. 2. (A) Autoradiographs of the amplification of ANP and b-actin
mRNA by RT-PCR followed by Southern blot analysis in the renal cortex,
outer and inner medullas from 3 representative normal control (NC2)
and 3 representative salt-restricted normal (SR) rats after a 7-day salt
restriction in the SR group. Each lane represents an individual rat. (B)
Relative ratios (mean 6 SEM) of the densitometry readings for RT-PCR
amplification of ANP and b-actin mRNA in the cortex, outer and inner
medulla from 15 normal control (NC2) and 14 salt-restricted normal (SR)
rats after a 7-day salt restriction. *P , 0.001 versus the NC2 group.
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salt restriction; (2) while urinary ANP excretion was signif-
icantly increased, it was accompanied by decreased urine
sodium excretion in water deprived and salt-restricted rats;
(3) RP-HPLC analysis revealed that 45% of the extracted
ANP in the water-deprived kidneys and only 3% in the
normal kidneys migrate in the molecular form of atrial
proANP; (4) atrial ANP mRNA expression and plasma
ANP concentration was significantly decreased after water
restriction; and (5) the seven-day salt restriction did not
reduce cardiac ANP mRNA expression or plasma ANP
concentration.
ANP is originally isolated and identified from rat and
human cardiac atrium. However, the presence of proANP-
like immunoreactive peptide and ANP mRNA has been
discovered in several extra-atrial tissues [10–13], including
the kidney [14–16]. In a search of the renal ANP gene
message, we [17, 18] and other investigators [21, 22] found
that the renal ANP mRNA was too low to be measured by
Northern blot hybridization. By using RT-PCR coupled
with Southern blot hybridization, we [17, 18] and others
[21, 22] previously demonstrated that a low abundance of
the ANP RNA message could be detected in the rat kidney
tissue. Moreover, we compared the relative amount of ANP
mRNA expression in the kidney as well as in cardiac tissues
by the combination of RT-PCR and Southern blot hybrid-
ization. Our results have shown that renal ANP mRNA
level were enhanced in diabetic [18] and DOCA salt-treated
[17] rats. In the present study, to our surprise, we show that
water deprivation and salt restriction markedly increase renal
ANP mRNA levels and urinary ANP excretion accompanied
with the decreases in cardiac atrial ANP mRNA levels and
plasma ANP concentrations in water-deprived rats. Fur-
thermore, in the water-deprived rat kidneys, an apparent
molecular form of ANP appeared to be cardiac atrial
proANP. This peptide could not to be of blood origin
because no ANP prohormone was detected in the plasma
of these rats. These results suggest a pathophysiological
role for renal-derived ANP as a paracrine or autocrine
function in the kidney.
ANP synthesized from the atrium is intimately linked to
changes in intravascular volume. Elevations of circulating
ANP can decrease cardiac output and arterial blood pressure
Fig. 3. Reverse phase—high-performance liquid chromatography (HPLC) profiles. (A) Kidney (5.0 g) from 3 normal control rats, (B) kidney (5.0 g)
from 3 water-deprived rats, (C) pooled plasma (2.5 ml) from 3 control rats, (D) pooled plasma (2.5 ml) from 3 water-deprived rats. Extracted samples
were applied to HPLC system equipped with a reverse-phase column (Cosmosil 5 C18-AR column). The column was eluted by increasing the ACN
concentration in Buffer B (60% ACN in 0.1% TFA). A linear gradient elution system was employed from 10% to 60% ACN by an increase in the ACN
concentration of 0.5% per minute. The flow rate was 1 ml/min, and fraction collection was 0.5 ml/tube. Elution positions for standard rat a-ANP-(1-28)
and rat atrial proANP are indicated by the arrows.
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[23] and alter the distribution of fluid across the capillary beds
[24]. However, many studies have shown that circulating
ANP is not a direct regulator of renal sodium excretion
[25]. This controversial assertion is made based on the fact
that plasma ANP levels do not correlate well with the
degree of natriuresis in common physiological and patho-
physiological conditions [25–31]. For instance, Goetz et al
demonstrated that left atrial distension in dogs after car-
diac denervation results in an elevation of plasma ANP
concentrations without a concomitant natriuresis. In con-
trast, the excretion of urine urodilatin (ANP-95-126), a
natriuretic peptide of renal origin, closely parallels renal
sodium excretion under various conditions that influence
body fluid regulation [28].
The enhancement of renal ANP synthesis found in our
[17, 18] and other [14] studies suggests that ANP synthe-
sized in the kidney is one of the factors responsible for fluid
and electrolyte homeostasis. This is to say that the kidney
itself may sense and regulate fluid-electrolyte imbalance by
the synthesis of ANP in the kidney to maintain fluid
homeostasis. The distribution of ANP receptors in the
nephron [32] suggests that renal synthesized natriuretic
peptide may act in a paracrine manner to modulate intra-
renal sodium and water homeostasis under some patho-
physiological conditions. In the present study, the finding
that markedly enhanced renal ANP synthesis with in-
creased urine ANP excretion rate in association with
decreased atrial ANP mRNA and plasma ANP level in
water-deprived rats provides the evidence to confirm the
hypothesis that local renal ANP may affect renal function
that is independent of cardiac ANP. In other words, the
present findings demonstrate that renal ANP and heart
ANP represent two distinct systems regulated by different
control mechanisms. Furthermore, levels of ANP mRNA in
renal outer and inner medullas were approximately eight-
fold and fivefold higher in salt-restricted rats than in
normal control rats, whereas ANP mRNA abundance in
the heart was not significantly affected by dietary salt
restriction. Similarly, in these salt-restricted animals, there
was no significant change in plasma ANP concentration
while urinary ANP excretion was increased. These findings
clearly indicate that the renal ANP system may first sense
and regulate the electrolyte imbalance prior to the re-
sponse of the cardiac ANP.
In the kidney, exogenous ANP exerts renal hemody-
namic and tubular actions that lead to increases in urinary
excretion of sodium, fluid and other electrolytes [2, 3]. In
our previous studies [17, 18] in which we considered plasma
volume expansion in DOCA-salt-treated rats and diabetic
Fig. 4. ANP mRNA expression from right atrium and left ventricles in
normal control (NC1) and water-deprived normal (WD) rats after a 4-day
water deprivation in the WD group. (A) Each of two representative
autoradiograms from NC1 and WD groups. (B) The relative ANP mRNA
levels of 14 NC1 and 12 WD rats. The density of each RNA sample
hybridized to the ANP probe was normalized to the b-actin probe. The
mean corrected density values of the SR group were further divided by
those of the NC1 group. *P , 0.05 versus the NC1 group.
Fig. 5. ANP mRNA expression from the right atrium and left ventricles
in normal control (NC2) and salt-restricted normal (SR) rats after a
7-day salt-restriction in the SR group. (A) Two representative autoradio-
grams from the NC2 and SR groups. (B) The relative ANP mRNA levels
of 15 NC2 and 14 SR rats. The density of each RNA sample hybridized to
the ANP probe was normalized to the b-actin probe. The mean corrected
density values of the SR group were further divided by those of the NC2
group. No statistical change was found between the SR group and NC2
group.
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rats, significantly increased urinary ANP excretion and
enhanced renal ANP mRNA expression, as well as a
significant correlation between urinary ANP excretion and
daily sodium excretion were found. These findings indicate
that ANP synthesized in the kidney is responsible for
diuresis and natriuresis in these volume-expanded diseases.
In fact, the influence of hydration status on the actions of
ANP on diuresis and natriuresis has been studied. In
several animal studies, elevation of urine flow and sodium
excretion occurred only in animals that were volume ex-
panded [33-35]. Conversely, water deprivation and salt
restriction in this study markedly increased renal ANP gene
expression and daily urine ANP excretion, but were also
associated with a profound reduction in the daily sodium
excretion and urine flow. These results strongly indicate
that it is unlikely that natriuresis and diuresis are the main
actions of endogenously-synthesized ANP from the kidney
in volume-depleted status.
In volume-depleted humans or experimental animals, a
profound increase of systemic vascular resistance, presum-
ably induced by the increased activity of renin-angiotensin
system [36], vasopressin release [37] and sympathetic ner-
vous system [38], has been noted. However, it has been
shown that renal blood flow fell only slightly or did not
change despite the strong elevation in the total peripheral
vascular resistance in this condition [36–38]. The mecha-
nisms responsible for the absence of an increase in renal
vascular resistance during volume depletion in the face of
the activated vasoconstrictive substances have been inves-
tigated [36–38]. In fact, many studies have confirmed that
vasodilators, such as prostaglandins, are produced in re-
sponse to the influence of volume depletion-induced ele-
vation of circulating or even intrarenal vasoconstrictive
substances, and therefore locally spare the renal circulation
from the vasoconstrictor effects without counteracting the
systemic vasoconstriction that may be necessary to preserve
blood pressure [36–38]. In addition to increased prosta-
glandin production, a marked increase of neural form of
the constitutive nitric oxide synthase mRNA levels with
parallel changes in the expression of renin and angio-
tensinogen mRNA in renal cortical tissues of rats on a
low-salt diet have been found recently [39]. The present
study has yielded similar results in which profoundly en-
hanced renal ANP synthesis in normal rats is accompanied
by the augmented plasma angiotensin II and vasopressin
concentrations after a four-day water deprivation or seven-
day salt restriction. In view of the ability of exogenous
administration of ANP to raise renal blood flow in descend-
ing and ascending vasa recta [40] and its antagonizing
action of vasoconstrictors [41], it is reasonable to propose
that ANP derived from the kidney may locally preserve
renal blood flow through counteracting the intrarenal va-
soconstrictve effect from circulating vasoconstrictive sub-
stances to help the autoregulation of the kidney.
In summary, the present study has shown that renal ANP
mRNA levels and urinary ANP excretion are markedly
enhanced, but urine sodium excretion is significantly de-
creased, in water-deprived and salt-restricted normal rats.
Water deprivation also decreases cardiac atrial ANP
mRNA expression, plasma ANP concentration and daily
urine volume. These results demonstrate that renal ANP
and cardiac ANP are two distinctly different systems that
may be regulated by different control mechanisms and may
have different functions in the kidney.
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